PARVG
Gamma-parvin
Also known as: PARVG_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HBI0
- Gene
- PARVG
- Ensembl
- ENSG00000138964
- Chromosome
- 22
- Canonical length
- 331 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
Members of the parvin family, including PARVG, are actin-binding proteins associated with focal contacts.[supplied by OMIM, Aug 2004]
Canonical amino-acid sequenceUniProt
331 residues, UniProt reviewed canonical sequence.
>Q9HBI0|PARVG
1 MEPEFLYDLL QLPKGVEPPA EEELSKGGKK KYLPPTSRKD PKFEELQKVL MEWINATLLP
61 EHIVVRSLEE DMFDGLILHH LFQRLAALKL EAEDIALTAT SQKHKLTVVL EAVNRSLQLE
121 EWQAKWSVES IFNKDLLSTL HLLVALAKRF QPDLSLPTNV QVEVITIEST KSGLKSEKLV
181 EQLTEYSTDK DEPPKDVFDE LFKLAPEKVN AVKEAIVNFV NQKLDRLGLS VQNLDTQFAD
241 GVILLLLIGQ LEGFFLHLKE FYLTPNSPAE MLHNVTLALE LLKDEGLLSC PVSPEDIVNK
301 DAKSTLRVLY GLFCKHTQKA HRDRTPHGAP NLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PARVG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 47 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 47 nTPM
- lymph node: 28 nTPM
- spleen: 28 nTPM
- appendix: 25 nTPM
- tonsil: 25 nTPM
- thymus: 17 nTPM
Single-cell type
- monocyte progenitors: 143 nCPM
- monocytes: 139 nCPM
- cdc: 125 nCPM
- pdcs: 109 nCPM
- macrophages: 98 nCPM
- neutrophil progenitors: 95 nCPM
Immune cell
- neutrophil: 73 nTPM
- eosinophil: 72 nTPM
- non-classical monocyte: 67 nTPM
- classical monocyte: 63 nTPM
- intermediate monocyte: 58 nTPM
- myeloid DC: 50 nTPM
Brain region
- white matter: 17 nTPM
- medulla oblongata: 15 nTPM
- thalamus: 15 nTPM
- pons: 12 nTPM
- cerebral cortex: 10 nTPM
- spinal cord: 10 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.9
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.28
- DepMap mean gene effect
- 0.16
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin cytoskeleton organization
- cell projection assembly
- cell-matrix adhesion
- establishment or maintenance of cell polarity regulating cell shape
- substrate adhesion-dependent cell spreading
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PARVG in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PARVG as an antibody target. Whether an autoantibody or antibody against PARVG could matter depends on whether native PARVG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PARVG is annotated at the cell surface, where native PARVG is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PARVG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...